Edition:
United States

Medtronic PLC (MDT)

MDT on New York Consolidated

86.74USD
28 Sep 2016
Change (% chg)

$0.07 (+0.08%)
Prev Close
$86.67
Open
$86.56
Day's High
$86.89
Day's Low
$86.16
Volume
3,208,101
Avg. Vol
4,632,943
52-wk High
$89.27
52-wk Low
$63.98

Select another date:

Wed, Sep 28 2016

BRIEF-Medtronic receives FDA clearance of TrailBlazer angled peripheral support catheter

* Medtronic receives FDA clearance of TrailBlazer angled peripheral support catheter

BRIEF-Medtronic receives FDA approval of first drug-coated balloon for treatment of in-stent restenosis

* Medtronic Plc says receives FDA approval of first drug coated balloon for treatment of in-stent restenosis

Medtronic's profit beats estimates on lower costs

Medtronic Plc , the world's largest standalone medical device maker, reported a better-than-expected quarterly profit, helped by lower costs and a lighter tax burden.

UPDATE 2-Medtronic's profit beats estimates on lower costs

* Shares down 1.2 pct in early trading (Adds details, forecast, updates shares)

Medtronic's quarterly revenue falls 1.5 pct

Aug 25 Medtronic Plc, the world's largest standalone medical device maker, reported a 1.5 percent dip in quarterly revenue, as sales for its heart, vascular and minimally invasive products fell.

BRIEF-Medtronic reports a passive stake of 8.6 pct in Mazor Robotics

* Medtronic Plc reports a passive stake of 8.6 pct in Mazor Robotics Ltd as of August 11, 2016 - SEC filing Source text for Eikon: Further company coverage:

BRIEF-Medtronic Plc CEO Omar Ishrak's 2016 total compensation was $15.3 mln versus $38.5 mln in 2015

* CFO Gary Ellis' FY 2016 total compensation $6.1 million versus $5.5 million in FY 2015

BRIEF-Medtronic CEO Omar Ishrak 2016 total compensation $15.3 mln

* CEO Omar Ishrak 2016 total compensation of $15.3 million versus $13.9 million in 2015 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

NuVasive settles spinal surgery patent fight with Medtronic

Medical device maker NuVasive Inc will pay rival Medtronic Plc $45 million to settle a longstanding patent fight related to spinal surgery technology, NuVasive said on Thursday.

NuVasive settles spinal surgery patent fight with Medtronic

Medical device maker NuVasive Inc will pay rival Medtronic Plc $45 million to settle a longstanding patent fight related to spinal surgery technology, NuVasive said on Thursday.

Select another date: